Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial
van de Vlasakker, Vincent C J, Guchelaar, Niels A D, van den Heuvel, Teun B M, Lurvink, Robin J, van Meerten, Esther, Bax, Ramon J F, Creemers, Geert-Jan M, van Hellemond, Irene E G, Brandt-Kerkhof, Alexandra R M, Madsen, Eva V E, Nederend, Joost, Koolen, Stijn L W, Nienhuijs, Simon W, Kranenburg, Onno, de Hingh, Ignace H J T, Verhoef, Cornelis, Mathijssen, Ron H J, Burger, Jacobus W A
Published in BMJ open (18.01.2024)
Published in BMJ open (18.01.2024)
Get full text
Journal Article